Log in
Log in
Or log in with
GoogleGoogle
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Tomás Dagá Gelabert
Age : 66
Public asset : 1,707,072 USD
Linked companies : Grifols, S.A. - Shanghai RAAS Blood Products Co., Ltd. - Biotest AG
Summary 
Founder of Osborne Clarke and Tojosnura SL, Tomás Dagá Gelabert occupies the position of External Director & Vice Secretary at Grifols SA, Secretary & Director at Araclon Biotech SL and Secretary at Progenika Biopharma SA (both are subsidiaries of Grifols SA), Secretary & Trustee at Fundació Víctor Grífols I Lucas and Secretary & Director at Barcelona Cartonboard S.A.U.

He is also Managing Partner at Tojosnura SL and Partner at Osborne Clarke and on the board of 18 other companies.

Tomás Dagá Gelabert received a graduate degree from the University of Barcelona.


Current positions of Tomás Dagá Gelabert 
NameTitle Since
Grifols, S.A.
(Pharmaceuticals)
External Director & Vice Secretary 2016
Shanghai RAAS Blood Products Co., Ltd.
(Pharmaceuticals)
Director 2020
Biotest AG
(Pharmaceuticals)
Vice Chairman-Supervisory Board 2022
Barcelona Cartonboard S.A.U. Secretary & Director -
Grifols Canada Therapeutics, Inc. Director -
Pbs Acquisition Corp. Director -
Chiquito Acquisition Corp. Director -
Fundació Víctor Grífols I Lucas Secretary & Trustee -
Probitas Foundation Trustee -
Kiro Grífols SL Director -
Grifols Worldwide Operations Ltd. Director -
Joaquim Molins Figueras Foundation Trustee -
Zambon SA Director -
Pharmazam SA Director -
Araclon Biotech SL Secretary & Director -
Biomat USA, Inc. Director -
BPC Plasma, Inc. Director -
Talecris Plasma Resources, Inc. Director -
Grifols USA, Inc. Director 2011
Scranton Enterprises BV Director -
Grifols Diagnostic Solutions, Inc. Director -
Alkahest, Inc. Director -
Tojosnura SL Managing Partner 2017
Progenika Biopharma SA Secretary -
Osborne Clarke Partner 2017


Holdings of Tomás Dagá Gelabert 
NameEquities%Valuation
Grifols, S.A. (GRF)
(Pharmaceuticals)
152,5760.036%1,707,072 USD


Tomás Dagá Gelabert: Personal Network 
Most Read News 
11/14Belgium's Proximus climbs as billionaire Niel buys stake
MR
11/27Elon Musk, Netanyahu tour ruins of Israeli kibbutz
RE
11/17White House condemns Musk for spreading 'hideous' antisemitic lie
RE
11/22LVMH heir Antoine Arnault to step back from Berluti management role
RE
11/22Factbox-LVMH roles held by Bernard Arnault's children
RE
11/17Fed's Collins: Not ready to say the rate hike cycle is over
RE
11/26Germany's Kuehne examines offer for Signa's Hamburg skyscraper -report
RE
05:10aElon Musk promises to wear symbol of Gaza hostages
RE
11/18Australian Forrests' Tattarang acquires 'iconic' hat company Akubra
RE
11/21Eni: John Kerry interested in fusion power plants
CF
More news


© 2023 People and Ownership :   
Tomás Dagá Gelabert : Connections 


-40% off Black Friday : Our subscriptions help you unlock the best investment opportunities.Enjoy this offer
Enjoy this offer